Literature DB >> 29331624

Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review.

Catalina Hernandez Torres1, Tina Hsu2.   

Abstract

CONTEXT: The number of older adults with cancer is expected to increase rapidly in the upcoming decades. Aging is heterogeneous and chronological age is often not reflective of biological age. A comprehensive geriatric assessment (CGA) is an in-depth assessment of multiple domains of health that results in better assessment of a patient's overall health and fitness and allows directed intervention to improve patient outcomes.
OBJECTIVE: To review the value of CGA for older adults with cancer, CGA composition and tools that can be utilized, and the feasibility of including CGA in oncologic practice. EVIDENCE ACQUISITION: The currently available evidence on CGA for older adults with cancer was reviewed. EVIDENCE SYNTHESIS: A CGA can highlight unidentified health problems and identify patients at higher risk of mortality, functional decline, surgical complications, chemotherapy intolerance, and chemotherapy toxicity. It has been shown that CGA is feasible in the oncology clinic, but geriatric screening tools may be useful to specifically identify patients who would benefit from a full CGA.
CONCLUSIONS: CGA is feasible and can identify patients at higher risk of adverse events such as mortality, functional decline, surgical complications, and chemotherapy toxicity. Clinicians should consider incorporating CGA when assessing and caring for older adults with cancer. PATIENT
SUMMARY: In this report, we review the benefits of a comprehensive geriatric assessment (CGA), a detailed in-depth assessment that identifies health problems not typically identified during routine assessments, for older adults with cancer. We describe the different domains of the CGA and suggest tools to utilize, as well as ways to incorporate CGA into the cancer care setting.
Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Comprehensive geriatric assessment; Geriatric screening tools; Older adults

Mesh:

Substances:

Year:  2018        PMID: 29331624     DOI: 10.1016/j.euf.2017.10.010

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  20 in total

1.  Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Authors:  Kazutaka Okita; Shingo Hatakeyama; Naoki Fujita; Sakae Konishi; Hayato Yamamoto; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Hiroyuki Ito; Kazuaki Yoshikawa; Takuya Koie; Chikara Ohyama
Journal:  Med Oncol       Date:  2018-11-26       Impact factor: 3.064

2.  The Relationship Between Frailty and Emotional Health in Older Patients with Advanced Cancer.

Authors:  Nikesha Gilmore; Lee Kehoe; Jessica Bauer; Huiwen Xu; Bianca Hall; Megan Wells; Lianlian Lei; Eva Culakova; Marie Flannery; Valerie Aarne Grossman; Ronak Amir Sardari; Himal Subramanya; Sindhuja Kadambi; Elizabeth Belcher; Jared Kettinger; Mark A O'Rourke; Elie G Dib; Nicholas J Vogelzang; William Dale; Supriya Mohile
Journal:  Oncologist       Date:  2021-09-19

Review 3.  Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care?

Authors:  Brian M Russell; Leora Boussi; Joaquim Bellmunt
Journal:  Drugs Aging       Date:  2022-03-28       Impact factor: 4.271

Review 4.  Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes.

Authors:  Nezahat Muge Catikkas; Zumrut Bahat; Meryem Merve Oren; Gulistan Bahat
Journal:  Aging Clin Exp Res       Date:  2022-02-15       Impact factor: 4.481

5.  Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists.

Authors:  Nikesha Gilmore; Huiwen Xu; Lee Kehoe; Amber S Kleckner; Kiran Moorthi; Lianlian Lei; Mostafa R S Mohamed; Kah Poh Loh; Eva Culakova; Marie Flannery; Erika Ramsdale; Paul R Duberstein; Beverly Canin; Charles Kamen; Gilbert Giri; Erin Watson; Amita Patil; Adedayo A Onitilo; Brian Burnette; Michelle Janelsins; Supriya G Mohile
Journal:  Cancer       Date:  2021-11-11       Impact factor: 6.921

6.  Managing older patients with heart failure calls for a holistic approach.

Authors:  Julia H I Wiersinga; Hanneke F M Rhodius-Meester; Emma E F Kleipool; Louis Handoko; Albert C van Rossum; Su-San Liem; Marijke C Trappenburg; Mike J L Peters; Majon Muller
Journal:  ESC Heart Fail       Date:  2021-04-08

7.  Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessment.

Authors:  Anne-Carina Scharf; Janine Gronewold; Christian Dahlmann; Jeanina Schlitzer; Andreas Kribben; Guido Gerken; Tienush Rassaf; Christoph Kleinschnitz; Richard Dodel; Helmut Frohnhofen; Dirk M Hermann
Journal:  BMC Geriatr       Date:  2019-08-14       Impact factor: 3.921

8.  Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy.

Authors:  Gregory T Chesnut; Amy L Tin; Daniel D Sjoberg; Brian Jang; Nicole Benfante; Saman Sarraf; Harry Herr; S Machele Donat; Guido Dalbagni; Bernard Bochner; Armin Shahrokni; Alvin C Goh
Journal:  J Urol       Date:  2020-09-08       Impact factor: 7.450

Review 9.  Use of Comprehensive Geriatric Assessment in Oncology Patients to Guide Treatment Decisions and Predict Chemotherapy Toxicity.

Authors:  Gobind R Tarchand; Vicki Morrison; Mark A Klein; Elyse Watkins
Journal:  Fed Pract       Date:  2021-05

10.  Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience.

Authors:  Rami Nassabein; Laura Mansour; Corentin Richard; Franck Vandenbroucke-Menu; Francine Aubin; Jean-Pierre Ayoub; Michel Dagenais; Real Lapointe; Richard Letourneau; Marylène Plasse; André Roy; Simon Turcotte; Mustapha Tehfe
Journal:  Curr Oncol       Date:  2021-05-18       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.